# FDA recall D-0153-2021

> **Taro Pharmaceuticals U.S.A., Inc.** · Class II · drug recall initiated 2020-11-17.

## Product

Kaiser Permanente Clotrimazole Cream USP, 1% Antifungal Cream, NET WT 1 oz (28.4 g), Manufactured by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T1C1 Distributed by Kaiser Foundation Hospitals Livemore, CA 94551-9756. Made in Canada. NDC 0179-8014-30

## Reason for recall

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

## Distribution

Distributed Nationwide in the USA and Canada

## Key facts

- **Recall number:** D-0153-2021
- **Recalling firm:** Taro Pharmaceuticals U.S.A., Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-11-17
- **Report date:** 2020-12-23
- **Termination date:** 2024-02-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Hawthorne, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0153-2021

## Citation

> AI Analytics. FDA recall D-0153-2021. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0153-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*